Hepatitis C virus-related resistance mechanisms to interferon α-based antiviral therapy
✍ Scribed by Wolf Peter Hofmann; Stefan Zeuzem; Christoph Sarrazin
- Book ID
- 116630692
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 222 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6
Pegylated interferon ␣ (PEG IFN-␣) improves sustained virological response rates in chronic hepatitis C, but neither its role in acute hepatitis C nor the biologic basis for its action has been defined. This prospective study assessed the efficacy of PEG IFN-␣ treatment in acute hepatitis C in relat